Baycol and Cholestasis - a phase IV clinical study of FDA data

Summary:

Cholestasis is found among people who take Baycol, especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months.

The phase IV clinical study analyzes which people take Baycol and have Cholestasis. It is created by eHealthMe based on reports of 19,127 people who have side effects when taking Baycol from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 28, 2023

19,127 people reported to have side effects when taking Baycol.
Among them, 12 people (0.06%) have Cholestasis.

What is Baycol?

Baycol has active ingredients of cerivastatin sodium. eHealthMe is studying from 19,129 Baycol users for its effectiveness, alternative drugs and more.

What is Cholestasis?

Cholestasis (a condition where bile cannot flow from the liver to the duodenum) is found to be associated with 2,035 drugs and 1,736 conditions by eHealthMe.

Number of Baycol and Cholestasis reports submitted per year:

Time on Baycol when people have Cholestasis *:

Gender of people who have Cholestasis when taking Baycol *:

female: 41.67 %
male: 58.33 %

Age of people who have Cholestasis when taking Baycol *:

Common drugs people take besides Baycol *:

Common side effects people have besides Cholestasis *:

Liver Function Tests Nos Abnormal: 6 people, 50.00%
Muscle Aches (muscle pain): 3 people, 25.00%
Fever: 3 people, 25.00%
Hepatic Necrosis (large portions of liver die off due to severe liver disease): 3 people, 25.00%
Rash Pruritic (redness with itching): 2 people, 16.67%
C-Reactive Protein Increased: 2 people, 16.67%
Choledocholithiasis (stones in the common bile duct): 2 people, 16.67%
Hepatic Failure (liver failure): 2 people, 16.67%
Malaise (a feeling of general discomfort or uneasiness): 2 people, 16.67%
Erythrocyte Sedimentation Rate Increased: 2 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Baycol and have Cholestasis?

Check whether Cholestasis is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Cholestasis and when was it recovered:

Cholestasis in Baycol

Expand to all the drugs that have ingredients of cerivastatin sodium:

Cholestasis and drugs with ingredients of cerivastatin sodium

Alternative drugs to, pros and cons of Baycol:

Baycol (19,129 reports)

Common Baycol side effects:

Browse all side effects of Baycol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Cholestasis treatments and more:

Cholestasis (21,220 reports)

COVID vaccines that are related to Cholestasis:

Common drugs associated with Cholestasis:

All the drugs that are associated with Cholestasis:

Cholestasis (2,035 drugs)

Common conditions associated with Cholestasis:

High blood pressure: 1,447 reports
Pain: 1,135 reports
Depression: 746 reports
Hiv infection: 556 reports
High blood cholesterol: 423 reports

All the conditions that are associated with Cholestasis:

Cholestasis (1,736 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cerivastatin sodium (the active ingredients of Baycol) and Baycol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.